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Abstract
Many drugs are weak bases and can be accumulated into liposomes in response to a pH gradient to achieve high internal
drug concentrations. This study is aimed at gaining an understanding of the relationship between the retention of the
fluoroquinolone antibiotic ciprofloxacin in liposomes and the intraliposomal form and location of this drug. 1H-NMR
spectroscopy was used to probe the interactions experienced by ciprofloxacin following uptake into large unilamellar
liposomes (LUV). It is shown that ciprofloxacin is located in the aqueous interior of the liposomes and is self-associated in
the form of small stacks. It does not precipitate out of solution even though the intraliposomal ciprofloxacin concentration
can exceed its solubility in aqueous solutions by almost two orders of magnitude. The results also indicate that little
entrapped ciprofloxacin partitions into the inner monolayer of the LUV. As a result of the lack of precipitation and rapid
exchange properties, ciprofloxacin can respond quickly to changes in electrochemical equilibria such as depletion of the pH
gradient. This provides a rationale for the rapid leakage of this drug in response to serum destabilization or depletion of the
pH gradient. 0005-2736 / 98 / $ ^ see front matter ß 1998 Elsevier Science B.V. All rights reserved.
Keywords: Nuclear magnetic resonance; Drug^membrane interaction; Fluoroquinolone; Transmembrane pH gradient; Drug loading;
Solubility
1. Introduction
Liposomes are widely used as carriers for anti-
cancer, antibiotic and antifungal drugs [1,2]. Encap-
sulation of drugs in liposomes can reduce their acute
toxicity and may result in increased e⁄cacy due to
the ability of small, long-circulating liposomes to
preferentially accumulate at the site of disease. In-
creased potency of antibiotics can occur as a conse-
quence of the natural clearance of liposomes from
the circulation by phagocytic cells, which are fre-
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Abbreviations: LUV, large unilamellar vesicles ; SUV, small
unilamellar vesicles ; vpH, transmembrane proton gradient;
DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; POPC, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; chol, cholester-
ol ; CHE, cholesteryl hexadecyl ether; CHES, 2-N-cyclohexylami-
noethanesulfonic acid; Hepes, N-2-hydroxyethylpiperazine-NP-2-
ethanesulfonic acid; RCF, relative centrifugal force; d/l ratio,
molar drug-to-lipid ratio (mol/mol)
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quently the site where intracellular pathogens localize
[3]. Cipro£oxacin, a synthetic quinolone derivative
with activity against a broad spectrum of Gram-pos-
itive and Gram-negative bacteria, is one of the most
widely used antibiotics for the treatment of respira-
tory, urinary and enteric infections [4,5]. Its bacterial
action results from the inhibition of the enzyme
DNA gyrase which is needed for the synthesis of
bacterial DNA [6,7]. However, the use of liposomal
carriers for cipro£oxacin is severely impaired by rap-
id leakage of this drug from liposomes.
Cipro£oxacin is one of a large number of drugs
with weak base character which can be actively ac-
cumulated in liposomes in response to a pH gradient
[8^10]. However, while some drugs such as the anti-
cancer drug, doxorubicin, are only slowly released
from the liposomal carrier in vitro or in vivo, other
drugs including cipro£oxacin leak out rapidly. In or-
der to improve these systems knowledge about the
relationship between retention and the form and lo-
cation of these drugs in liposomes is important. En-
capsulated drugs could be partitioned in the mem-
brane, reside in the aqueous interior as a precipitate
or remain in solution. The nature and location of the
drug in the liposome interior together with factors
such as membrane permeability determine how
quickly the encapsulated drug can respond to distur-
bances of thermodynamic equilibria such as deple-
tion of the pH gradient.
Cipro£oxacin loaded into liposomes in response to
transmembrane pH gradients has been suggested to
be precipitated out in the liposome interior [11]. Rea-
sons proposed for its rapid release in vitro and in
vivo were larger solubility product than other drugs
which are precipitated, other kind of drug associa-
tion within the vesicles, pK values close to neutrality
which results in higher fractions of the neutral mem-
brane-permeable form or rupture of the liposomal
membrane by growing crystals.
This study was aimed at achieving a better under-
standing of the factors which determine the retention
of cipro£oxacin after accumulation into large unila-
mellar vesicles driven by a transmembrane proton
gradient (vpH), where the vpH was generated in
response to entrapped ammonium sulfate. Because
of the sensitivity of NMR signals to changes in mo-
lecular environment and dynamics, the interaction of
cipro£oxacin with itself and with phospholipid
vesicles was investigated using 1H-NMR spectro-
scopy. It is shown that cipro£oxacin is located in
the aqueous interior of the liposomes in the form
of stacks consisting of a small number of cipro£ox-
acin molecules. The drug is not precipitated although
the intraliposomal cipro£oxacin concentration can
exceed its solubility by orders of magnitude. This is
the ¢rst time such a phenomenon has been observed
in a liposomal system. Previous work has shown that
other drugs such as doxorubicin can be entrapped at
concentrations substantially higher than their aque-
ous solubility; however, this can be explained by
precipitation or partitioning into the liposome mem-
brane [9,12]. The high solubility of entrapped cipro-
£oxacin together with the rapid exchange into and
out of the lipid membrane allow it to respond very
quickly to changes in thermodynamic equilibria such
as depletion of the pH gradient.
2. Materials and methods
2.1. Materials
Dipalmitoylphosphatidylcholine (DPPC) and pal-
mitoyl-oleoyl PC (POPC) were purchased from
Avanti Polar Lipids (Alabaster, AL), and were
s 99% pure. Cholesterol (chol) and ammonium sul-
fate (AS) were obtained from Sigma (St. Louis, MO),
and deuterium oxide (D2O) and sodium 2,2-di-
methyl-2-silapentane-5-sulfonate (DSS) from Cam-
bridge Isotope Laboratories (Andover, MA).
[14C]Cholesteryl hexadecyl ether (CHE) was custom
synthesized by DuPont New England Nuclear (Bos-
ton, MA), [3H]CHE, [3H]methylamine, [14C]sucrose
and [3H]glucose were from DuPont as well. Normal
mouse serum was purchased from Cedar Lane Lab-
oratories (Hornby, ON, Canada). Cipro£axacin hy-
drochloride as well as [14C]cipro£oxacin were a gift
from INEX Pharmaceuticals (Vancouver, B.C., Can-
ada).
2.2. Preparation of liposomes
DPPC/chol (55:45 mol/mol) liposomes were pre-
pared by dissolving the lipids in t-butanol and lyo-
philizing for 6 h. POPC was directly used for the
preparation of POPC liposomes. Multilamellar
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vesicles (MLVs) were formed by hydrating the lipid
with a 300 mM ammonium sulfate solution followed
by ¢ve freeze^thaw cycles [13]. The lipid concentra-
tion was approximately 100 mM. The resulting
MLVs were directly extruded 10 times through two
stacked Nuclepore polycarbonate ¢lters with pore
sizes of 80, 100 and 200 nm to obtain LUVs of cor-
responding sizes. The size of the vesicles was mea-
sured by dynamic light scattering (Nicomp Particle
Sizing Systems, Santa Barbara, CA). Average hydro-
dynamic diameters were found to be 115 þ 20 nm and
190 þ 30 nm for the DPPC/chol LUVs extruded
through 100 and 200 nm ¢lters, respectively, and
75 þ 20 nm and 155 þ 30 nm for POPC LUVs ex-
truded through 80 and 200 nm ¢lters. Lipid concen-
trations were determined using the phosphorus assay
of Fiske and Subbarow [14].
2.3. Generation of the pH gradient
The ammonium sulfate gradient was generated by
exchanging the extravesicular solution with 150 mM
sodium chloride (NaCl) on G-50 Sephadex spin col-
umns [15]. This concentration gradient drives the
formation of a pH gradient of approximately 3 units.
For the NMR experiments the spin columns had to
be repeatedly washed with a 150 mM NaCl/D2O
solution in order to remove residual ethanol in the
Sephadex gel. The pH gradient was determined using
[14C]methylamine and was performed as previously
described [16].
2.4. Uptake of cipro£oxacin into LUVs
Cipro£oxacin was added to these liposomes and
the samples were incubated for 15 min at 60‡C. En-
capsulation e⁄ciencies were determined as follows.
Residual unentrapped drug was removed by size ex-
clusion chromatography on Sephadex G50 spin col-
umns and cipro£oxacin concentrations determined
by scintillation counting using [14C]cipro£oxacin or
UV-absorption at 274 nm after a Bligh^Dyer extrac-
tion into 200 mM NaOH as aqueous phase [17].
Lipid concentrations were determined either by scin-
tillation counting using the radiolabeled lipid
[3H]CHE or by the Fiske^Subbarow phosphorus as-
say. Typical encapsulation e⁄ciencies for molar
drug-to-lipid (d/l ; mol/mol) ratios up to 0.6 were
between 90% and 95%. The average size of the lipo-
somes was not a¡ected by the uptake of the drug as
was shown by dynamic light scattering measure-
ments.
2.5. Drug release experiments
In vitro release experiments were carried out in test
tubes by diluting samples 1:1 with normal mouse
serum and incubation at 37‡C. The pH gradient
was depleted by incubation in 150 mM ammonium
acetate solution at 25‡C. Samples at various time
points were taken and concentrations of entrapped
drugs were determined following removal of unen-
trapped drug by size exclusion chromatography as
described above for drug uptake experiments.
2.6. Trapped volume determination
Trapped volumes of the liposomes were deter-
mined under the same conditions as for the drug
uptake using radiolabeled sucrose or glucose as aque-
ous trap markers. 100 Wmol DPPC/chol (55:45
mol%) were hydrated in 1 ml of a 300 mM ammo-
nium sulfate, 10 mM sucrose or glucose solution
spiked with 0.5 WCi [14C]sucrose or [3H]glucose, re-
spectively, freeze^thawed and extruded as described
above. The external solution containing unentrapped
marker was exchanged against a 150 mM sodium
chloride solution on Sephadex G50 spin columns.
The lipid concentrations were determined by the
phosphorus assay and the amount of trapped radio-
active marker as well as total marker in the initial
lipid dispersion by liquid scintillation counting.
Trapped volumes were expressed as Wl of trapped
aqueous volume per Wmol of total lipid. The internal
volume of 200 nm DPPC/chol LUVs was 2.0 þ 0.1
Wl/Wmol lipid.
2.7. Solubility
Solubilities were determined at 25‡C as a function
of ammonium sulfate concentration and pH and in
the presence of liposomes. For the concentration de-
pendence, excess drug was added to 5 mM sodium
acetate solutions containing the appropriate amounts
of ammonium sulfate. If necessary the pH was ad-
justed to pH 5. DPPC/chol liposomes in 25 mM ace-
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tate bu¡er at pH 5 were added to 10 mM cipro£ox-
acin in water. Lipid concentrations ranged from 5 to
20 mM. Subsequently ammonium sulfate was added
to a concentration of 300 mM. It was not necessary
to readjust the pH. The pH dependence was deter-
mined in 300 mM ammonium sulfate solutions which
were titrated with NaOH to the appropriate pHs.
The solutions contained 3 mM CHES, Hepes and
citric acid to allow better pH adjustment. No attempt
was made to keep the ionic strength constant since
its increase by NaOH addition has no signi¢cant
e¡ect on the solubility at 300 mM ammonium sul-
fate. Subsequently the samples were equilibrated for
24 h at 25‡C and the concentration of cipro£oxacin
determined after centrifugation for 15 min at
3000Ug in the supernatant by UV absorption at
274 nm, as described previously.
2.8. Binding studies
Binding studies were performed using a Beckmann
TL-100 ultracentrifuge with a TLA 100.2 ¢xed-angle
rotor. DPPC/chol 200 nm LUVs (2.5 mM lipid) were
incubated in the presence of increasing concentra-
tions of cipro£oxacin (0.25^10 mM) at 25‡C for 2 h
in 20 mM sodium acetate/100 mM NaCl (pH 5) and
pelleted by ultracentrifugation for 90 min at a
RCFmax of 436 000Ug (100 000 rpm). The superna-
tants as well as the lipid pellets were assayed for drug
and lipid using the methods described above. The
pellets were quickly rinsed with cold bu¡er and re-
suspended in H2O. The amount of drug associated
with the lipid pellets makes up a few percent (93%)
of the total drug. This, however, does not take the
aqueous volume which is included in the pellets into
account. Therefore, the actual amount of partitioned
drug is even lower. The lipid in the supernatant was
less than 5%. The level of association cannot be de-
termined by assaying the drug in the supernatant
using £uorescence or UV spectroscopy, as it corre-
sponds to the accuracy of the measurements.
2.9. 1H-NMR experiments
All salts used in the 1H-NMR experiments were
dissolved in D2O and subsequently lyophilized to
exchange protons against deuterons. This procedure
was repeated once. Whenever D2O was used as the
solvent, pH-meter readings are reported rather than
pD values (pD values can be derived by adding 0.4
units to the pH-meter reading [18]). The 1H-NMR
experiments were performed on a Bruker MSL 200
FT-NMR spectrometer operating at 200 MHz (47 T).
If not otherwise mentioned, the temperature was
maintained at 20‡C. Typically, the pulse width was
2.5 Ws (60‡ pulse) and the interpulse delay 3 s (the
longest T1 was 0.9 s). The digital resolution was
0.244 Hz/point with a spectral width of 2000 Hz.
An exponential multiplication corresponding to
0.5 Hz line broadening was applied to the free
induction decay prior to Fourier transformation.
The chemical shifts are referenced to external sodium
2,2-dimethyl-2-silapentane-5-sulfonate (DSS). The
spin-lattice relaxation times, T1, were measured by
the inversion-recovery method (180‡^d^90‡ pulse se-
quence). In all T1 experiments the incrementation of
the recovery interval was nonmonotonic in order to
avoid systematic errors. Peak heights were used for
the calculation of T1s. Assignments were made in
accordance with 1H-NMR spectra published else-
where for cipro£oxacin and related £uoroquinolones
[19^21]. The H5 and H8 protons were distinguished
by the relative splitting of the signal. Due to its close
proximity to the £uorine in position 6, H5 was
assigned to the signal with the larger coupling con-
stant. The structure of cipro£oxacin is shown in Fig.
1. The central structural unit is a quinolone ring
which has a £uorine atom at the 7-position, a piper-
azine moiety at the 6-position, a cyclopropyl ring at
position 3 and a carboxyl group at position 1. The
pK values are 6.0 for the carboxyl group and 8.8 for
the 4P nitrogen [22].
Fig. 1. Structure of cipro£oxacin. The central structural unit is
a quinolone ring with a £uorine atom at the 7-position, a piper-
azine moiety at the 6-position, a cyclopropyl ring at position 1
and a carboxyl group at position 3. There are two pK values,
pKa;COOH = 6.0 and pKa;N40 = 8.8.
BBAMEM 77443 9-9-98
N. Maurer et al. / Biochimica et Biophysica Acta 1374 (1998) 9^2012
2.10. Line-broadening calculations
In the following it is demonstrated how exchange
of cipro£oxacin between the membrane and the
aqueous phase can lead to signi¢cant broadening of
the NMR signals, even though the membrane-asso-
ciated fraction is very small. The exchange process
can be described by equations which were derived for
nuclear relaxation in solutions containing paramag-
netic ions where exchange occurs between the coor-
dination shell of the paramagnetic ion and the bulk
solvent [23,24]. They were speci¢cally applied to
study the di¡usion of water across lipid bilayers,
where the internal and external water were distin-
guished by the presence of paramagnetic ions in ei-
ther compartment [25,26]. The spin^spin relaxation is
responsible for the line broadening (vX= 1/ZT2). The
observed relaxation times, T2, depend on the popu-
lation fractions and exchange rate (1/dex) according
to:
T2  paqpmemT2;mem  dex 1
where T2;mem is the relaxation time in the membrane
in the absence of exchange, paq and pmem the popu-
lation fractions of cipro£oxacin in the aqueous phase
and the membrane, and dex the exchange time of
cipro£oxacin between aqueous phase and membrane
(or the average residence time of cipro£oxacin in the
membrane) [26].
Although insu⁄cient information is available con-
cerning the parameters in Eq. 1 to calculate T2, a
lower limit can be estimated from a theoretical lower
bound for T2;mem. The lower limit for T2;mem is at-
tained if the molecules enter the membrane in a cer-
tain state (orientation, conformational state) and exit
the membrane without undergoing a change of state.
In this case the NMR line shape can be approxi-
mated by a Gaussian function and the free induc-
tion signal is given by FID(t)Vexp3M22t2=2V
exp3t2=2T22;eff ) with an e¡ective T2;effw(1/M2)1=2
[27]. Abragam [28] gives the following formula for
the second moment M2j of a spin j coupled by dipo-
lar interactions to N spins k (k = 1,2,TN) having
the same gyromagnetic ratio, Q, as spin j :
M2j  3=5Q4X2II  1
P
1=r6jk, where I is the spin
of each nucleus and rjk the distance from spin j to
spin k [28]. T2;eff can be taken as a lower limit for T2
in the membrane: T2;memvT2;eff = (1/M2)1=2 = 2.3U
1036r (Aî )3 (for r = 4 Aî , T2;memv 1.5U1034 s and
for r = 2 Aî , T2;memv 1.8U1035 s). Eq. 1 leads to
the inequality T2v (paq/pmem)T2;mem, thus yielding
an upper limit to the predicted line broadening
(vX= 1/ZT2) due to the exchange process. Represen-
tative upper limits to the line width for pmem = 0.03
are vX9 67 Hz for r = 4 Aî and vX9 549 Hz for r =
2 Aî , respectively. The majority of distances of neigh-
boring protons in cipro£oxacin are within 3 Aî (for a
modeled three-dimensional structure of cipro£oxacin
see NIH Three Dimensional Drug Structure Bank at
http://cmm.info.nih.gov/modeling/drugbank.html).
3. Results
3.1. Cipro£oxacin is released rapidly from LUVs
in the presence of serum
It has been demonstrated that cipro£oxacin can be
accumulated to high concentrations inside liposomes
in response to a transmembrane pH gradient
[11,29,30]. This is illustrated in Fig. 2. Cipro£oxacin
is rapidly accumulated into DPPC/chol LUVs at
60‡C, with the uptake going to completion within 5
min. However, it is also rapidly released from the
LUVs on incubation in 50% mouse serum at 37‡C
or depletion of the pH gradient at 25‡C in 150 mM
ammonium acetate (Fig. 2, right side). Serum pro-
teins permeabilize the membrane, whereas ammo-
nium acetate dissipates the pH gradient by equilibra-
tion of ammonia and acetic acid across the
membrane. Cipro£oxacin is also released upon exter-
nal addition of ammonium sulfate. From this it is
evident that cipro£oxacin is able to respond rapidly
to changes of thermodynamic equilibria.
3.2. Cipro£oxacin does not precipitate in
the liposome interior
The concentration of cipro£oxacin inside lipo-
somes can be very high (up to 300 mM). The solu-
bility of cipro£oxacin was determined under the con-
ditions prevailing inside the liposomes. The internal
pH after uptake was found to be 4.9 þ 0.1 utilizing
radiolabeled methylamine. Before uptake the internal
ammonium sulfate concentration is 300 mM; how-
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ever, the ammonium concentration is reduced by the
amount of cipro£oxacin loaded into the LUVs dur-
ing uptake. Fig. 3 shows the solubility of cipro£ox-
acin as a function of ammonium sulfate concentra-
tion at 25‡C and pH 5, the inset describes the pH
dependence in 300 mM ammonium sulfate solutions.
The cipro£oxacin precipitate had the form of white
needles. The presence of liposomes (5^20 mM DPPC/
chol) had no signi¢cant e¡ect on the solubility of
cipro£oxacin in 300 mM ammonium sulfate solution
at pH 5 and 3. The solubility at pH 5 and 300 mM
ammonium sulfate is 5 mM and increases to about
8.5 mM at pH 3. Solubilities were slightly lower in
D2O than in H2O (20^30%). The intraliposomal con-
centration of cipro£oxacin at a molar drug-to-lipid
ratio of 0.5, 90^95% uptake and an internal volume
of 2 Wl/Wmol lipid for 200 nm DPPC/chol LUVs is
between 225^240 mM. This exceeds the solubility of
free cipro£oxacin by almost 50-fold.
The 1H-NMR spectrum of cipro£oxacin loaded
into 200 nm DPPC/chol LUVs at a drug-to-lipid
ratio of 0.5 is depicted in Fig. 4a. For comparison
the spectra of the free drug at the same concentration
as used for the uptake and that of empty DPPC/chol
liposomes are included (Fig. 4b,c). Two features of
the spectrum of encapsulated cipro£oxacin are prom-
inent. First, all resonances are clearly visible though
signi¢cantly broadened. The integrated intensities are
within 10% of those of the same amount of free
cipro£oxacin. Second, large up¢eld shifts of the ar-
omatic proton resonances (H2, H5, H8) as compared
to free cipro£oxacin are observed. The small satellite
peaks correspond to non-encapsulated cipro£oxacin
in the external medium. The encapsulation e⁄ciency
was 90% with 10% external cipro£oxacin as deter-
mined using the procedures described under Section
Fig. 2. Time course of a typical uptake of cipro£oxacin into
200 nm DPPC/chol LUVs at a d/l ratio of 0.3 and incubation
at 60‡C for 30 min (open circles). Cipro£oxacin was loaded us-
ing the ammonium sulfate gradient technique with 300 mM am-
monium sulfate. The full symbols represent the release of cipro-
£oxacin from the LUVs in 50% mouse serum (full circles) and
in 150 mM ammonium acetate (depletion of the pH gradient,
full squares).
Fig. 3. Solubility of cipro£oxacin as a function of ammonium
sulfate concentration at pH 5. The pH corresponds to the inter-
nal pH after uptake of cipro£oxacin into 200 nm DPPC/chol
LUVs at a d/l ratio of 0.5. The inset gives the solubility in
300 mM ammonium sulfate solutions as a function of pH. Ex-
periments were repeated three times.
Fig. 4. (a) 1H-NMR spectrum of cipro£oxacin loaded into
200 nm DPPC/chol LUVs (d/l = 0.5). Approximately 90% of
drug is inside the liposomes. The rest is in the external medium
represented by the small satellite peaks in the low ¢eld region.
(b) 1H-NMR spectrum of cipro£oxacin in 150 mM NaCl solu-
tion in the absence of liposomes at the same concentration as
was used for the uptake above (ccipro = 9 mM). The assignments
of the aromatic resonances are given in the ¢gure. For a full
assignment of all proton resonances see Fig. 5A. The signals of
protons H5 and H8 overlap. They can be distinguished by their
relative splittings. H5 has the larger coupling constant. (c) 1H-
NMR spectrum of 200 nm DPPC/chol LUVs (c = 40 mM). The
trimethylammonium resonance of the lipid phosphocholine
head group is indicated.
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2. The solubility data predict that cipro£oxacin
should precipitate inside the liposomes. Formation
of crystals, however, would lead to disappearance
of NMR resonances due to the line broadening asso-
ciated with the immobilization of the molecules. Pre-
cipitation of free cipro£oxacin induced by increasing
the pH of the solution results in a proportional loss
of signal with no broadening of the lines.
3.3. Cipro£oxacin molecules self-associate into
small stacks
Experiments were performed to demonstrate that
the tendency of cipro£oxacin molecules to self-asso-
ciate in small stacks in aqueous solution also occurs
in the LUV interior. Before describing the experi-
ments, the interactions a¡ecting the NMR spectra
are described brie£y. The interactions of aromatic
molecules with themselves in solution and their pack-
ing in crystals are governed by strong attractive in-
teractions between the aromatic Z-systems [31,32]. As
a consequence of these Z^Z interactions, cipro£ox-
acin molecules form stacks in aqueous solutions as
well as in crystals where the molecules lie on top of
each other in an head-to-tail arrangement [19,33].
The self-association process in aqueous solution de-
pends on concentration and is highly dynamic with
molecules constantly associating and dissociating.
Monomers exist only at concentrations below
1 mM. In NMR experiments, the ring currents asso-
ciated with the circulation of the Z electrons in the
plane of the aromatic rings lead to a shielding of
protons above and below this plane [34]. The signals
of these protons, which in our case are located on
neighboring molecules, will appear up¢eld shifted.
The extent of stacking increases with increasing
concentration. This is illustrated in Fig. 5 for cipro-
£oxacin in D2O by the increasing up¢eld shifts of the
aromatic proton resonances. Spectra of cipro£oxacin
in D2O at 5 mM (bottom) and 115 mM (top) are
depicted in Fig. 5A, whereas the relative changes of
the chemical shift values as a function of concentra-
tion are plotted in Fig. 5B. The e¡ect of cipro£ox-
acin concentration on the shifts of the non-aromatic
proton resonances are comparatively small. The
chemical shift values are listed in Table 1. The line
widths are not signi¢cantly a¡ected at any concen-
tration. In these experiments the pH was not ad-
justed. It was shown elsewhere that below pH 5 there
is practically no e¡ect of pH on chemical shifts [21].
The highest pH in these experiments was 4.8.
Inside liposomes cipro£oxacin shows the same be-
havior as far as stacking is concerned. Increasing the
drug-to-lipid ratio from 0.05 to 0.7 leads to increas-
ing up¢eld shifts, the ring protons are a¡ected most
(Fig. 6, Table 2). The small satellite peaks again cor-
respond to non-encapsulated cipro£oxacin. The
shifts are much larger for encapsulated cipro£oxacin
than for cipro£oxacin free in solution. This can be
attributed to the much higher cipro£oxacin concen-
Fig. 5. Stacking of cipro£oxacin molecules with increasing con-
centrations demonstrated by the increased up¢eld shifts of the
aromatic proton signals. The other resonances are much less af-
fected. (A) 1H-NMR spectra of cipro£oxacin in D2O at 5 mM
(bottom) and 115 mM (top). Spectra were normalized to the
same height. (B) Changes of chemical shift values with concen-
tration relative to 5 mM cipro£oxacin (vN = N5 mM cipro3
Nx mM cipro). Chemical shift values are listed in Table 1. The aro-
matic protons are represented by the open symbols, the closed
symbols indicate the non-aromatic protons. H2 (a), H5 (O),
H8 (E), H20 , H60 (b), H30 , H50 (F), H10 (R), H11 (S).
BBAMEM 77443 9-9-98
N. Maurer et al. / Biochimica et Biophysica Acta 1374 (1998) 9^20 15
trations inside the liposomes (up to 300 mM). In
addition, the di¡erent counterions, chloride for the
concentration dependence of the drug alone and sul-
fate inside the liposomes, may a¡ect the shifts
slightly di¡erently. A concentration series in ammo-
nium sulfate solutions is not possible because of the
low solubility of cipro£oxacin (5 mM in 300 mM
ammonium sulfate at pH 5, see Fig. 4).
3.4. Interaction of cipro£oxacin with the lipid bilayer
is responsible for the line broadening
The line widths of entrapped cipro£oxacin de-
crease with increasing concentration (see Fig. 6, Ta-
ble 2). The broadest lines were obtained at the lowest
drug-to-lipid ratio (d/l = 0.05) where the internal ci-
pro£oxacin concentration is in the range of 25 mM.
This is in contrast to the behavior of cipro£oxacin in
solution where the line width did not change signi¢-
cantly with increasing concentration up to 115 mM
which is just slightly less than its solubility in D2O.
The broadening also appears larger in POPC lipo-
somes than in DPPC/chol LUVs (Table 2). External
addition of cipro£oxacin to 200 nm POPC liposomes
with no transmembrane pH gradient leads to signi¢-
cant line broadening (Fig. 7 and Table 2, d/l = 0.5
with 150 mM NaCl in- and outside). The line width
of the H2 proton increases with decreasing concen-
tration much more than the others (not shown). The
width of the water peak does not change in the pres-
ence of liposomes. Fig. 7a,c are the spectra of cipro-
£oxacin alone in 150 mM NaCl and cipro£oxacin
loaded into POPC liposomes at the same d/l ratio.
Therefore, the main contribution to the line broad-
ening must arise from an interaction of cipro£oxacin
with the liposomes.
3.5. Only a small proportion of cipro£oxacin
partitions into the lipid bilayer
Binding studies performed by ultracentrifugation
demonstrated that the amount of cipro£oxacin asso-
ciated with DPPC/chol liposomes is less than 3% of
the total amount of drug initially added (for the con-
ditions see Section 2). This percentage was deter-
mined by assaying the lipid pellet and does not ac-
count for the drug in the aqueous volume included in
the pellet. A determination in the supernatant was
not possible since its accuracy corresponds to the
level of association. Therefore, this 3% value repre-
sents an upper limit for the amount of drug associ-
ated with the lipid. This corresponds to a maximum
partition coe⁄cient, Kp, of 0.03, where Kp = cmem/caq
with caq and cmem being the concentrations of drug in
the membrane and aqueous phase, respectively.
These data clearly indicate that almost all (v 97%)
of the drug is located in the aqueous interior of the
liposomes. This is also corroborated by integration
Fig. 6. 1H-NMR spectra of cipro£oxacin loaded into 200 nm
DPPC/chol LUVs at di¡erent d/l ratios. Only the down¢eld re-
gions with the aromatic proton resonances are shown. The d/l
ratios increase from the bottom to the top in the order 0.05,
0.25, 0.5 and 0.7. The small satellite peaks are drug in the ex-
ternal medium. The line widths are listed in Table 2.
Table 1
Chemical shifts of cipro£oxacin alone in D2O and cipro£oxacin
taken up into 200 nm DPPC/chol and POPC LUVs
H2 H8 H5 H20 ,H60 H30 ,H50 H10 H11
A. Cipro£oxacin in D2Oa
5 mM 8.721 7.580 7.662 3.618 3.528 1.422 1.209
9 mM 8.672 ^ 7.566 3.614 3.528 1.426 1.205
25 mM 8.545 7.450 7.355 3.599 3.526 1.418 1.173
50 mM 8.449 7.381 7.204 3.581 3.518 1.406 1.137
75 mM 8.386 7.334 7.107 3.563 3.510 1.392 1.108
107 mM 8.340 7.301 7.038 3.551 3.507 1.384 1.087
B. Uptake into 200 nm DPPC/chol LUVs
d/l 0.05 8.447 7.350 ^ 1.405 1.124
d/l 0.25 8.165 7.162 6.810 1.332 0.998
d/l 0.5 8.112 7.116 6.718 1.308 0.960
d/l 0.7 8.085 7.106 6.690 1.300 0.942
C. Uptake into 200 nm POPC LUVs
d/l 0.5 8.119 7.144 6.746
aThe coupling constants are 7.1 Hz for H8, 13 Hz for H5 and
6 Hz for H10.
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of the NMR spectra of free and entrapped drug (see
above). A further quantitation was not attempted.
In addition, if signi¢cant amounts of drug were
associated with the lipid e¡ects on the lipid head-
group, proton resonances would be expected. The
trimethyl ammonium group should be particularly
a¡ected by the ring currents associated with the ar-
omatic rings of cipro£oxacin if signi¢cant amounts
of cipro£oxacin reside in close proximity (6 8 Aî ).
Shifts between 10 Hz and more than 100 Hz have
been found for benzylalcohol, indole-3-acetic acid,
aromatic lipophilic drugs such as dibucaine as well
as the surface potential probe ANS (1-anilino-8-
naphthalenesulfonate) [35^38]. However, uptake of
cipro£oxacin into 80 nm diameter POPC liposomes
does not result in an up¢eld shift of the trimethyl
lipid headgroup protons, even at a d/l ratio of 0.5.
Addition of Pr3 to the external medium separates
the signal of the trimethyl protons of the inner
monolayer from that of the outer by shifting the
latter down¢eld [39]. The signal from the inner
monolayer remained essentially unchanged (shifted
up¢eld by 1^2 Hz) in the presence of entrapped drug.
The above data indicate that self-association and
lipophilicity can be excluded as the source of line
broadening for encapsulated cipro£oxacin. The
most likely explanation involves rapid exchange of
drug into and out of the membrane, where only a
small fraction of drug actually resides in the mem-
brane.
4. Discussion
Many drugs, which are weak bases, can be accu-
mulated to high concentrations in liposomes in re-
sponse to a transmembrane proton gradient. How-
ever, uptake and retention properties are strongly
drug dependent. For example, accumulation of drugs
such as doxorubicin leads to high levels of drug up-
take and excellent retention [8,9,12,40,41]. Alterna-
tively, drugs such as cipro£oxacin exhibit poor reten-
tion properties. The interrelationship between the
retention properties of cipro£oxacin loaded into
LUVs and its nature and location inside liposomes
is the subject of this study. The following discussion
will focus on the anomalous solubility of cipro£ox-
acin and the lack of precipitation in the liposome
interior, and second, the exchange of cipro£oxacin
into and out of the lipid membrane with regard to
NMR line-broadening e¡ects.
The cipro£oxacin concentrations inside liposomes
can exceed 250 mM. However, the drug does not
precipitate inside the liposomes even though the sol-
ubility of cipro£oxacin in bulk aqueous solution
under the same pH and ionic strength conditions as
in the liposome interior is only 5 mM. Self-associa-
Fig. 7. 1H-NMR spectra. (b) External addition of cipro£oxacin
to 200 nm POPC LUVs in the absence of a transmembrane
proton gradient (d/l = 0.5, ccipro = 9 mM). (a) 9 mM cipro£ox-
acin in 150 mM NaCl solution. (c) uptake of cipro£oxacin into
200 nm POPC LUVs (d/l = 0.5, ccipro = 9 mM).
Table 2
Line widths (full width at half maximum), vX1=2 (Hz), of cipro-
£oxacin in solution, after uptake into 200 nm DPPC/chol and
POPC LUVs and upon external addition to 200 nm POPC
LUVs exhibiting no transmembrane proton gradient
H2 H8 H5 H10 H11
A. Cipro£oxacin free in solution
5 mM 3.8 ^ ^ 13 10.4
115 mM 3.8 12 16.6 13.6 10.9
B. Uptake into 200 nm DPPC/chol LUVs
d/l 0.25 29.6 28.9 44.4 22.7 24.9
d/l 0.5 21.8 22.2 38.0 20.8 20.7
d/l 0.7 14.8 18.6 29.4 ^ 18.5
C. Uptake into 200 nm POPC LUVs
d/l 0.5 24.4 32.6 35.9
D. External addition of cipro£oxacin to 200 nm POPC LUVs
d/l 0.1 37.8 28.8a
d/l 0.25 23.8 26.6a
d/l 0.5 15.2 23a
aH5 and H8 overlap, vX1=2 is their combined width.
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tion of cipro£oxacin molecules into small stacks is
observed. The extent of stacking as indicated by
the up¢eld shifts of the NMR lines is larger in the
liposome interior due to the higher internal drug
concentrations. The reason for the anomalously
high solubility of cipro£oxacin in the LUV interior
remains obscure. One possibility concerns the nature
of the water in the LUV interior. It is known that the
properties of water at interfaces and con¢ned to
small spaces are very di¡erent from that of bulk
water. Water is highly structured at interfaces, with
lower density and higher viscosity than bulk water
[42,43]. The distances over which the water structure
is a¡ected is a matter of dispute, estimates range
from 10^30 Aî up to 1000 Aî [44,45]. Anomalous
properties of water were also reported in Sephadex
gels where the internal water could dissolve signi¢-
cant amounts of water-insoluble dyes [46,47].
An alternative possibility is that the phospholipid
surface may act as an inhibitor of crystallization in
the same way as macromolecules exert speci¢c con-
trol of mineralization processes [48^50]. Biomimetic
studies of mineral formation in synthetic phospholi-
pid vesicles have shown that the lipid composition
has a dramatic e¡ect on the precipitation kinetics
and the size and location of the intravesicular pre-
cipitate [51]. For example, the rate and extent of
precipitation of calcium phosphate in the interior
of liposomes was extremely low in the presence of
10 mol% phosphatidic acid (PA), but not in the pres-
ence of other anionic phospholipids [52,53].
The results presented here indicate that almost all
(v 97%) of the encapsulated drug is located in the
aqueous interior of the liposomes. Nevertheless, all
1H-NMR resonances are considerably broadened
with line widths up to 45 Hz as compared to 4^15
Hz for free cipro£oxacin (see Table 2). The decrease
in line widths at high intraliposomal cipro£oxacin
concentrations and the negligible e¡ect of stacking
on line widths rules out self-association and precip-
itation of cipro£oxacin as sources of broadening.
However, exchange of cipro£oxacin between the
membrane and the aqueous phase is a reasonable
mechanism for the observed line broadening (see Sec-
tion 2.10). According to this model, the NMR reso-
nances are broader the higher the fraction of cipro-
£oxacin in the membrane and/or the ‘faster’ the
exchange (see Section 2, Eq. 1). For water exchange
between the bulk solution and the aqueous interior
of DPPC SUVs it has been shown that dex dominates
the relaxation times at low temperatures [26]. The
partition coe⁄cient of small molecules for POPC
membranes is higher than for DPPC/chol membranes
[54^56]. This could explain why cipro£oxacin reso-
nances are broader in POPC than in DPPC/chol lipo-
somes. The fact that the line widths decrease with
increasing internal cipro£oxacin concentrations can
be explained by considering the change in relative
population fractions. Reduced pmem or higher paq
lead to a decrease in line width. Increasing the total
concentration of cipro£oxacin causes an increase in
the fraction of drug in the aqueous phase when the
membrane is saturated. Concomitantly, a second
competing exchange process, the increased self-asso-
ciation of cipro£oxacin with increasing concentra-
tion, may contribute to reduce the amount of the
exchangeable species, the monomer.
The high solubility of cipro£oxacin in the intra-
liposomal space and its ability to rapidly exchange
into and out of a lipid membrane correlate well with
the high tissue penetration of this drug and its accu-
mulation within mammalian cells, factors which are
responsible for the broad spectrum of activity of the
£uoroquinolone antibiotics against extracellular as
well as intracellular pathogens [57^59].
Finally, strategies to improve the retention of ci-
pro£oxacin are discussed. While depletion of the pH
gradient results in rapid leakage of cipro£oxacin
from liposomes other drugs such as doxorubicin
are retained much longer. Thus the e¡ect of the pH
gradient can be modulated by other parameters. Pre-
cipitation of drugs in the liposome interior as well as
drug partitioning into the lipid bilayer have been
identi¢ed as leakage retarding factors [9,12,41]. In a
subsequent study we have shown that the retention
of cipro£oxacin can be improved upon inclusion of
negatively charged lipids into the LUV formulations
consistent with the partitioning model [29,41].
In summary, cipro£oxacin does not precipitate in-
side liposomes following accumulation in response to
a transmembrane pH gradient even though the inter-
nal drug concentration can be much higher than its
solubility in the bulk aqueous phase. In addition,
only a very small proportion of the entrapped drug
can partition into the inner monolayer of the LUV.
We suggest that the soluble nature of internalized
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cipro£oxacin is directly related to the rapid leakage
of the drug following changes in electrochemical
equilibria.
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